Epidemiology of COVID-19: Risk Factors, Rates & Prevention
This paper provides an epidemiological analysis of COVID-19, examining the key risk factors associated with disease severity, including age, pre-existing conditions, and behavioral factors such as smoking. It outlines the primary transmission routes of SARS-CoV-2 and walks through the calculation of epidemiological measures including incidence rate, prevalence rate, mortality rate, and odds ratio using hypothetical population data. The paper also distinguishes among the three levels of prevention — primary, secondary, and tertiary — and concludes by proposing a research question focused on effective interventions for high-risk populations with pre-existing conditions, noting the appropriateness of both observational and experimental study designs.
- Introduction: COVID-19 Risk Factors and Transmission: Key risk factors and transmission routes of COVID-19
- Calculating Incidence and Prevalence Rates: Step-by-step incidence and prevalence rate calculations
- Mortality Rate and Odds Ratio Analysis: Mortality rate derivation and odds ratio for severe outcomes
- Levels of Prevention: Primary, secondary, and tertiary prevention frameworks explained
- Conclusion and Research Implications: Proposed research question and study design recommendations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It grounds abstract epidemiological concepts in concrete hypothetical calculations, helping readers understand how incidence, prevalence, mortality, and odds ratios are derived in practice.
- The paper moves logically from risk and transmission through quantitative measures to prevention frameworks and finally to a proposed research question, creating a coherent analytical arc.
- Each epidemiological metric is clearly defined before being calculated, making the analysis accessible to readers who may be encountering these concepts for the first time.
Key academic technique demonstrated
The paper demonstrates applied quantitative reasoning within a public health context. Rather than simply defining epidemiological terms, it applies them to a worked example using hypothetical population figures — a technique that shows the student can translate theoretical knowledge into practical analysis. The use of an odds ratio to link pre-existing conditions with severe outcomes, followed by a proposed study design, also models the bridge from descriptive to analytical epidemiology.
Structure breakdown
The paper opens with a discussion of risk factors and transmission modes supported by peer-reviewed citations. It then presents step-by-step calculations for incidence, prevalence, and mortality rates before analyzing an odds ratio scenario. A section on the three levels of prevention follows, framing disease management across the care continuum. The conclusion translates the OR finding into a specific research question and recommends study designs, tying the quantitative analysis back to real-world public health significance.
Introduction: COVID-19 Risk Factors and Transmission
COVID-19, caused by the SARS-CoV-2 virus, has been associated with several significant risk factors. Age and pre-existing health conditions — such as cardiovascular disease, diabetes, chronic respiratory disease, and cancer — are prominent factors that increase the severity of the disease (Rahman et al., 2021). Behavioral factors, like smoking, can also exacerbate the risk (Ko et al., 2020).
The primary mode of transmission for COVID-19 is through respiratory droplets released when an infected person coughs, sneezes, or talks (Ko et al., 2020). The virus can also spread by touching surfaces contaminated with the virus and then touching the face. A study published in The Lancet confirmed these modes of transmission, suggesting the need for hand hygiene and respiratory precautions (Chu et al., 2020).
Calculating Incidence and Prevalence Rates
To calculate incidence, one divides the number of new cases in a specific time frame by the at-risk population. Prevalence is determined by dividing the total number of cases (new and existing) during the same timeframe by the current population. Assuming a global population of 7.821 billion at the beginning of the period, 20 million new cases reported within a year, and a total of 50 million cases (both new and existing) by the end of the year, the calculated rates are as follows:
Incidence Rate: Approximately 255.72 new cases per 100,000 people in the population. This reflects the frequency of new cases occurring during the year.
Prevalence Rate: Approximately 639.30 total cases per 100,000 people in the population. This indicates how widespread the condition is at a particular point in time, considering all cases — both new and pre-existing.
Mortality Rate and Odds Ratio Analysis
The mortality rate is calculated by dividing the number of deaths by the number of confirmed cases. This rate provides insight into the lethality of the disease. Using a scenario of 1,500,000 deaths from 50,000,000 confirmed cases of COVID-19, the calculated mortality rate is 3.0%. This means that for every 100 confirmed cases, there were 3 deaths attributed to the virus.
The odds ratio (OR) is a measure of association between an exposure and an outcome. An OR greater than 1 indicates a positive association; less than 1 indicates a negative association. For COVID-19, examining the OR can reveal how strongly factors such as pre-existing conditions are associated with severe disease outcomes. Using the following hypothetical data:
The calculated odds ratio is 6.0. This suggests that the odds of patients with pre-existing conditions experiencing severe disease outcomes are 6 times higher than for those without pre-existing conditions.
Conclusion and Research Implications
Given the high odds ratio for severe outcomes in patients with pre-existing conditions, a possible research question could be: "What are the effective intervention strategies to reduce the risk of severe COVID-19 outcomes among patients with pre-existing conditions?"
An observational study could be appropriate for initial exploration of the effectiveness of existing interventions, while an experimental study might be used to test new interventions in a controlled setting.
This research would be significant for public health as it could inform targeted prevention strategies to protect high-risk groups, ultimately reducing the burden of severe disease outcomes on the healthcare system.
References
Chu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Schünemann, H. J., ... & Reinap, M. (2020). Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. The Lancet, 395(10242), 1973–1987.
Ko, J. Y., Danielson, M. L., Town, M., Derado, G., Greenlund, K. J., Kirley, P. D., ... & COVID-NET Investigation Group. (2020). Risk factors for COVID-19-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system. medRxiv, 2020-07.
Rahman, M. M., Bhattacharjee, B., Farhana, Z., Hamiduzzaman, M., Chowdhury, M. A. B., Hossain, M. S., ... & Uddin, M. J. (2021). Age-related risk factors and severity of SARS-CoV-2 infection: A systematic review and meta-analysis. Journal of Preventive Medicine and Hygiene, 62(2), E329.
Always verify citation format against your institution’s current style guide requirements.